CS Medica A/S
ISIN: DK0061668225 | Ticker: CSMED | LEI: 549300SC8KWO7JFWLN17
Country: Denmark
CS MEDICA is a Danish-based MedTech combining science and nature with the purpose of creating products for a better every day. By using modern technology to research and utilize different compounds found in the cannabis plant, we create world-changing products that offer efficient and safe treatment of autoimmune and stress-related disorders.
Founded in 2016, we discovered an untapped potential for the use of cannabinoids in the healthcare treatment sector and in 2021, after extensive research and development, we launched medical device products across international markets, supplying people worldwide with an efficient, safe OTC alternative. As we continue to research, develop, manufacture, commercialize and build brands, we aim to revolutionize the medical and cannabis industries, with science and nature in our hearts.
2011
Served areaWorldwide
HeadquartersFruebjergvej 3, 2100 Copenhagen – Denmark
| Line item in (dkk) | 01.10.2020 | 01.10.2021 | 01.10.2022 |
|---|---|---|---|
| Assets | 5,436,210.00 | 27,411,163.00 | 27,905,519.00 |
| Noncurrent Assets | 3,903,058.00 | 13,086,052.00 | 17,129,579.00 |
| Deferred Tax Assets | 451,637.00 | 226,543.00 | 3,505,709.00 |
| Longterm Deposits | 0.00 | 82,187.00 | 109,012.00 |
| Current Assets | 1,533,152.00 | 14,325,111.00 | 10,775,941.00 |
| Work In Progress | 0.00 | 64,428.00 | 0.00 |
| Finished Goods | 1,120,781.00 | 1,164,684.00 | 1,348,534.00 |
| Current Trade Receivables | 46,287.00 | 1,635,557.00 | 6,493,623.00 |
| Other Current Receivables | 69,200.00 | 1,464,357.00 | 0.00 |
| Cash | 296,885.00 | 9,996,085.00 | 2,933,783.00 |
| Equity | 87,241.00 | 24,147,367.00 | 24,926,543.00 |
| Issued Capital | 80,000.00 | 708,630.00 | 800,971.00 |
| Retained Earnings | 7,241.00 | 16,287,572.00 | 16,689,693.00 |
| Liabilities | 5,436,210.00 | 27,411,163.00 | 27,905,519.00 |
| Noncurrent Liabilities | 4,335,516.00 | 1,644,012.00 | 759,872.00 |
| Other Longterm Provisions | 494,850.00 | 329,900.00 | 164,948.00 |
| Deferred Tax Liabilities | 759,313.00 | 0.00 | 0.00 |
| Longterm Borrowings | 1,356,973.00 | 1,314,112.00 | 594,924.00 |
| Current Liabilities | 1,013,453.00 | 1,619,784.00 | 2,219,105.00 |
| Trade And Other Current Payables To Trade Suppliers | 466,665.00 | 504,157.00 | 1,186,419.00 |
| Other Current Payables | 400,807.00 | 710,932.00 | 584,660.00 |
| Line item in (dkk) | 01.10.2020/ 01.10.2021 |
01.10.2021/ 01.10.2022 |
|---|---|---|
| Revenue | 3,179,557.00 | 10,583,029.00 |
| Other Income | 1,987,950.00 | 736,265.00 |
| Cost Of Merchandise Sold | 1,503,381.00 | 5,962,393.00 |
| Employee Benefits Expense | 738,835.00 | 7,459,971.00 |
| Depreciation And Amortisation Expense | 1,367,452.00 | 2,075,780.00 |
| Profit Loss From Operating Activities | -176,047.00 | -13,334,133.00 |
| Profit Loss Before Tax | -407,786.00 | -14,162,592.00 |
| Income Tax Expense Continuing Operations | -1,055,415.00 | -3,359,620.00 |
| Profit (loss) | 647,629.00 | -10,802,971.00 |
| Line item in (dkk) | 01.10.2021 | 01.10.2022 |
|---|---|---|
| Profit (loss) | 647,629.00 | -10,802,971.00 |
| Adjustments For Finance Costs | 231,738.00 | 828,459.00 |
| Cash Flows From Used In Operating Activities | -6,018,964.00 | -14,041,570.00 |
| Cash Flows From Used In Investing Activities | -4,162,220.00 | -2,813,316.00 |
| Interest Paid Classified As Financing Activities | 231,738.00 | 828,459.00 |
| Cash Flows From Used In Financing Activities | 19,880,384.00 | 9,792,585.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 9,699,200.00 | -7,062,301.00 |
Please note that some sums might not add up.
DK0061668225
LEI549300SC8KWO7JFWLN17
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.